Výsledky vyhledávání - "D. G. Kieback"

Midline intravaginal slingplasty for treatment of urinary stress incontinence: results of an independent audit up to 2 years after surgery

Autor: Dagmar-C. Fischer, Marga M. IJland, Greg McGrath, D. G. Kieback, Bruce Farnsworth

Publikováno v: International Urogynecology Journal. 16:447-454

Recently, the midline intravaginal slingplasty (anterior IVS) directed at reinforcing the pubourethral ligament was introduced for treatment of urinary stress incontinence. An independent telephone interview to evaluate urinary symptoms and surgery-r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bad4ba6d8855f1560f49a61be06cde8
https://doi.org/10.1007/s00192-004-1276-z

Zobrazit plný text záznamu

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

Autor: F. Orlandi, L. Mellars, Raphael Catane, Nely Wigler, D. G. Kieback, E. Grischke, Piotr Tomczak, L. Alland, Stephen P. Ackland, Armando Santoro, C. Tendler, R. Rosso, Moshe Inbar, Mary O'Brien

Publikováno v: Annals of Oncology. 15:440-449

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX (TM)/Doxil (R)) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Background: This study was designe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9ed4de6b6ef36a25566c803c0590d4f
https://doi.org/10.1093/annonc/mdh097

Zobrazit plný text záznamu

Adenovirus-Mediated Thymidine Kinase Gene Therapy for Recurrent Ovarian Cancer: Expression of Coxsackie-Adenovirus Receptor and Integrins αvβ3 and αvβ5

Autor: Raymond H. Kaufman, M. Orlowska-Volk, Dagmar-Christiane Fischer, X Tong, E. Aguilar-Cordova, A. Hasenburg, Ibrahim Ramzy, D G Kieback, A. Rojas-Martinez, P. Kohlberger

Publikováno v: Journal of the Society for Gynecologic Investigation. 9:174-180

Ten patients with recurrent ovarian cancer received a combined treatment of optimal tumor debulking, adenovirus-mediated herpes simplex virus thymidine kinase gene therapy (GT), and systemic application of acyclovir or valacyclovir and topotecan. Bio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61c37e3191178b1d4c12bffc5ebc04f2
https://doi.org/10.1177/107155760200900310

Zobrazit plný text záznamu

Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer

Autor: Annette Hasenburg, Ibrahim Ramzy, Dagmar-C. Fischer, P. Kohlberger, Estuardo Aguilar-Cordova, D. G. Kieback, M Orlowska-Volk, X W Tong, C. Nyberg-Hoffman, Raymond H. Kaufman, Augusto Rojas-Martinez

Publikováno v: International Journal of Gynecologic Cancer. 12:66-73

Hasenburg A, Fischer DC, Tong X-W, Rojas-Martinez A, Nyberg-Hoffman C, Orlowska-Volk M, Kohlberger P, Kaufman RH, Ramzy I, Aguilar-Cordova E, Kieback DG. Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes sim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a255d920978a6544098ff8b36a8c6c7
https://doi.org/10.1136/ijgc-00009577-200201000-00011

Zobrazit plný text záznamu

Topotecan Chemotherapy in Patients with Breast Cancer and Brain Metastases: Results of a Pilot Study

Autor: G. von Minckwitz, D. G. Kieback, H.J. Staab, Rachel Würstlein, Jörn Hilfrich, H. Deertz, M. Mesrogli, A. E Schindler, C. Oberhoff, C. van Soest, Jalid Sehouli

Publikováno v: Oncology Research and Treatment. 24:256-260

Symptomatic brain metastases occur in approximately 10-15% of patients suffering from breast cancer and are linked to a clear deterioration of the patient's condition. Although radiotherapy is recommended as a primary therapy, the optimal management

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c11f1e2048356bdf38eef3b0c023fb8
https://doi.org/10.1159/000055088

Zobrazit plný text záznamu

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

Autor: R. Kreienberg, Andrew K. Godwin, Ingo B Runnebaum, E Stickeler, Harvey A. Risch, Roxana Moslehi, O Olipade, Caryn Lerman, Barbara L. Weber, D G Kieback, Shan Wang-Gohrke, W Weikel, Steven A. Narod, Danny Vesprini, Jean Sébastien Brunet, John Abrahamson

Publikováno v: British Journal of Cancer

Two biallelic polymorphisms in introns 3 and 6 of the p53 gene were analysed for a possible risk-modifying effect for ovarian cancer. Germline DNA was genotyped from 310 German Caucasian ovarian cancer patients and 364 healthy controls. We also typed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::068aaddd5673f6663d6bba3889890dd0
http://europepmc.org/articles/PMC2374363

Zobrazit plný text záznamu

Validation of IHC4 algorithms for prediction of risk of recurrence in early breast cancer using both conventional and quantitative IHC approaches

Autor: Cornelis J.H. van de Velde, Christos Markopoulos, Mark Gustavson, David L. Rimm, Luc Dirix, Jason Christiansen, Hein Putter, Daniel Rea, T Robson, Caroline M. Seynaeve, John M. S. Bartlett, Annette Hasenburg, D. G. Kieback

Publikováno v: Journal of Clinical Oncology, 30(15)

517 Background: Hormone receptors, HER2 and Ki67 are residual risk markers in early breast cancer. Combining these markers into a unified algorithm (IHC4) provides information on residual recurrence risk of patients treated with hormone therapies. Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7676e14c415c32ffa251b6155ad10023
https://hdl.handle.net/1887/100263

Zobrazit plný text záznamu

Adenovirus-mediated thymidine kinase gene therapy induces apoptosis in human epithelial ovarian cancer cells and damages PARP-1

Autor: D G, Kieback

Publikováno v: In vivo (Athens, Greece). 23(1)

Adenoviral (ADV) gene therapy with the thymidine kinase gene (TK) under control of the Rous sarcoma virus (RSV) promotor followed by the administration of acyclovir leads to replication errors in transcription and to cell death. This concept of ADV-R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::20a072d072225dbebcbddbd40d4ef68c
https://pubmed.ncbi.nlm.nih.gov/19368128

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání